Dual diagnosis refers to individuals who have both a substance use disorder and a co-occurring mental health disorder.
Tolerance refers to the need for increased amounts of a substance to achieve the same effect, indicating adaptation by the body.
Cognitive Behavioral Therapy (CBT) is effective in treating substance use disorders by helping clients identify and change harmful thought patterns and behaviors.
The Precontemplation stage is when the individual is not yet considering change or is unaware of the need to change.
The DSM-5 provides criteria for diagnosing substance use disorders and other mental health conditions.
Trauma and stress are significant psychological factors that can contribute to the onset and continuation of substance use disorders.
Alcohol is classified as a depressant because it slows down brain function and neural activity.
Tolerance (needing more of the substance to achieve the same effect) and withdrawal symptoms are key indicators of substance use disorder.
Dopamine plays a key role in the brain's reward system, and its release is often stimulated by substances of abuse, leading to pleasurable effects.
Genetic predisposition is a well-established risk factor for developing substance use disorders.
The biopsychosocial model considers the interplay of biological, psychological, and social factors in the development and maintenance of addiction.
